IDDS-Discovery Lead Optimization - DLO
The Discovery and Lead Optimization™ and process compares the properties of various lead compounds and provides information to help select the leads with the greatest potential to be developed into safe and effective medicines, and in alignment with corporate strategy. Often during this stage of development,
lead prioritization studies are conducted in living organisms (in vivo)
and in cells in the test tube (in vitro) to compare various lead compounds
and how they are metabolized and affect the body.
(See also: Solution Profile on Microsoft Site)
Our Lead Optimization solution has the following features:
- Facilitates identification of leads in alignment with corporate strategy.
- Toll-gated funnel maturation process for identifying, maturing and classifying new leads, including a configurable data model with key metadata such as general information, physicochemical properties, protein binding, bioavailability, toxicity, efficacy, and others.
- Provides team workspaces, collaboration and communication tools, and document/data management systems for work-in-progress.
- Enables preparation of a decision support package for Leads investigation and prospect identification
- Enables definition and simulation of what-if scenarios.
- Interactive tabular, graphing and mapping drilldown dashboards for Corporate Strategy, Portfolios, and Leads
- Provides interfaces to various corporate applications
To Learn More
Email:
Call: +1 (650) 350-1900